WebJul 7, 2024 · Antineoplastic are defined as medications used to treat cancer. Antineoplastic drugs are also called anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs. To determine if a drug is classified as hazardous please check the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings (2016) the list is not all-inclusive. Web4.6.4 The investigational product(s) should be stored as specified by the sponsor (see 5.13.2 and 5.14.3) and in accordance with applicable regulatory requirement(s). 4.6.5 The investigator should ensure that the investigational product(s) are used only in accordance with the approved protocol.
PART 312—INVESTIGATIONAL NEW DRUG APPLICATION
WebThe procedures should address adequate and safe receipt, handling, storage, dispensing, retrieval of unused product from subjects, and return of unused investigational product(s) to the sponsor (or alternative disposition if authorized by the sponsor and in compliance with the applicable regulatory requirement(s)). 5.14.4 The sponsor should: WebStudy with Quizlet and memorize flashcards containing terms like Which of the following is an important component of drug accountability?, Who has ultimate responsibility for an … challis idaho county
æ 1168 ç Compounding for Phase I Investigational Studies,
WebThe sponsor shall, in accordance with ICH GCP Art. 5.14.5a, take measures to ensure the stability of the investigational product (s) during the period of use. This includes the transport of investigational medicinal products. In principle, investigational medicinal … WebA. Destruction or disposition of investigational products 1. Unused investigational drug containers a. In cases of drug expiration or end of trial, with sponsor approval destruction will be documented in Vestigo, UVA’s electronic drug accountability system, where a certificate of destruction is retrievable. WebReturn any unused investigational agents at the completion of the study or upon notification that an agent is being withdrawn. Food and Drug Administration, 21 C.F.R. 312 Investigational New Drug Application (FDA, Rockville, Md., April 2005); 21 C.F.R. 211 Current Good Manufacturing Practice for Furnished Pharmaceuticals ... challis idaho earthquake 2019